Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Chimerix (CMRX)

Chimerix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CMRX
DateTimeSourceHeadlineSymbolCompany
24/01/202521:01GlobeNewswire Inc.Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
13/01/202512:00GlobeNewswire Inc.Chimerix to Speak Today at The White House Cancer Moonshot ForumNASDAQ:CMRXChimerix Inc
10/01/202520:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
10/01/202520:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
10/01/202519:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
10/01/202519:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
10/01/202519:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
10/01/202519:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
30/12/202412:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
30/12/202412:00GlobeNewswire Inc.Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse GliomaNASDAQ:CMRXChimerix Inc
10/12/202414:55AllPennyStocks.comSmall Cap Soars On FDA Submission PlansNASDAQ:CMRXChimerix Inc
10/12/202413:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
09/12/202421:01GlobeNewswire Inc.Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-EndNASDAQ:CMRXChimerix Inc
06/12/202421:01GlobeNewswire Inc.Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
14/11/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
11/11/202412:00GlobeNewswire Inc.Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO MeetingNASDAQ:CMRXChimerix Inc
07/11/202412:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMRXChimerix Inc
07/11/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
07/11/202412:00GlobeNewswire Inc.Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
01/11/202411:00GlobeNewswire Inc.Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024NASDAQ:CMRXChimerix Inc
31/10/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
18/10/202420:31GlobeNewswire Inc.Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
03/09/202411:00GlobeNewswire Inc.Chimerix to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:CMRXChimerix Inc
30/08/202420:05GlobeNewswire Inc.Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
13/08/202420:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CMRXChimerix Inc
13/08/202411:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMRXChimerix Inc
13/08/202411:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMRXChimerix Inc
13/08/202411:00GlobeNewswire Inc.Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:CMRXChimerix Inc
09/08/202417:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CMRXChimerix Inc
09/08/202416:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMRXChimerix Inc
 Showing the most relevant articles for your search:NASDAQ:CMRX

Your Recent History

Delayed Upgrade Clock